Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00561782 · ClinicalTrials.gov registry record
MR Spectroscopy as a Diagnostic and Outcome Measure in Pain and SCI
A clinical trial of Spinal Cord Injury and Hyperalgesia, Secondary, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 94
- Enrollment target
- 1
- Study location
NCT00561782 is a study of Spinal Cord Injury and Hyperalgesia, Secondary that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 94 participants, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00561782, a study of Spinal Cord Injury and Hyperalgesia, Secondary, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare the changes that occur in sensation and chemical properties of the brain following SCI between individuals that experience chronic pain and those that do not, and between those with SCI and the able-bodied.
Conditions Studied
Study Locations (1)
Florida
- VA Medical Center, Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00561782
The ClinicalTrials.gov registry entry for NCT00561782 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 85-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (11% higher). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 0 interventions.
NCT00561782 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00561782 about?
NCT00561782 is a clinical study titled "MR Spectroscopy as a Diagnostic and Outcome Measure in Pain and SCI". The goal of this study is to compare the changes that occur in sensation and chemical properties of the brain following SCI between individuals that experience chronic pain and those that do not, and between those with SCI and the able-bodied.
What is the current status of trial NCT00561782?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2007-10. Estimated completion is 2010-11.
What conditions does trial NCT00561782 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Hyperalgesia, Secondary, Hyperalgesic Sensations.
Who is sponsoring clinical trial NCT00561782?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00561782 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
Spinal Cord Injury Registry - North American Clinical Trials Network
RECRUITING
-
Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.